Clarity Pharmaceuticals Common Stock

Clarity Pharmaceuticals (CU6.AX) currently reports a common stock of $450M as of June 2026. That compares with $260M in the prior-year period — up 76.2% year over year. Use the charts on this page to explore Clarity Pharmaceuticals's common stock history and peer comparisons.

Clarity Pharmaceuticals's common stock increased from $260M to $450M — a 76.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clarity Pharmaceuticals reported $450M in common stock as of June 2026. That compares with $260M in the prior-year period — up 76.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $450M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clarity Pharmaceuticals, and consider following CU6.AX for alerts when major investors trade the stock.